238 related articles for article (PubMed ID: 29924296)
21. ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.
Dreyling M; Thieblemont C; Gallamini A; Arcaini L; Campo E; Hermine O; Kluin-Nelemans JC; Ladetto M; Le Gouill S; Iannitto E; Pileri S; Rodriguez J; Schmitz N; Wotherspoon A; Zinzani P; Zucca E
Ann Oncol; 2013 Apr; 24(4):857-77. PubMed ID: 23425945
[TBL] [Abstract][Full Text] [Related]
22. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
van de Velde CJ; Boelens PG; Borras JM; Coebergh JW; Cervantes A; Blomqvist L; Beets-Tan RG; van den Broek CB; Brown G; Van Cutsem E; Espin E; Haustermans K; Glimelius B; Iversen LH; van Krieken JH; Marijnen CA; Henning G; Gore-Booth J; Meldolesi E; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten H; Schmoll HJ; Smith JJ; Tanis PJ; Taylor C; Wibe A; Wiggers T; Gambacorta MA; Aristei C; Valentini V
Eur J Cancer; 2014 Jan; 50(1):1.e1-1.e34. PubMed ID: 24183379
[TBL] [Abstract][Full Text] [Related]
23. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer.
Stahel R; Thatcher N; Früh M; Le Péchoux C; Postmus PE; Sorensen JB; Felip E;
Ann Oncol; 2011 Sep; 22(9):1973-1980. PubMed ID: 21727198
[TBL] [Abstract][Full Text] [Related]
24. Implementation of a Systematic Literature Search Strategy in a National Breast Cancer Guideline: The Relevance of Systemic Therapy in Lymph Node Recurrent Disease.
Stüber TN; Stangl S; Jackisch C; Janni W; Brucker SY; Hartkopf A; Gerber B; Budach W; Lux MP; Wöckel A
Oncol Res Treat; 2018; 41(9):554-559. PubMed ID: 30114683
[TBL] [Abstract][Full Text] [Related]
25. Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelines.
Pavlidis N; Stahel R; Hansen H; Cervantes A
Ann Oncol; 2011 Sep; 22 Suppl 6():vi7-11. PubMed ID: 21908509
[No Abstract] [Full Text] [Related]
26. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
Wierda WG; Byrd JC; Abramson JS; Bilgrami SF; Bociek G; Brander D; Brown J; Chanan-Khan AA; Chavez JC; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lim MS; Ma S; Malek S; Mato A; Mosse C; Shadman M; Siddiqi T; Stephens D; Sundaram S; Wagner N; Dwyer M; Sundar H
J Natl Compr Canc Netw; 2020 Feb; 18(2):185-217. PubMed ID: 32023533
[TBL] [Abstract][Full Text] [Related]
27. NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019.
Wierda WG; Byrd JC; Abramson JS; Bilgrami SF; Bociek G; Brander D; Brown J; Chanan-Khan AA; Chavez JC; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Ma S; Malek S; Mato A; Mosse C; Neppalli VT; Shadman M; Siddiqi T; Stephens D; Wagner N; Dwyer MA; Sundar H
J Natl Compr Canc Netw; 2019 Jan; 17(1):12-20. PubMed ID: 30659125
[TBL] [Abstract][Full Text] [Related]
28. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Bielack S; Abecassis N; Aro HT; Bauer S; Biagini R; Bonvalot S; Boukovinas I; Bovee JVMG; Brennan B; Brodowicz T; Broto JM; Brugières L; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Dhooge C; Eriksson M; Fagioli F; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gaspar N; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hecker-Nolting S; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kager L; Kasper B; Kopeckova K; Krákorová DA; Ladenstein R; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Morland B; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Strauss SJ; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv79-iv95. PubMed ID: 30285218
[No Abstract] [Full Text] [Related]
29. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.
Hoang-Xuan K; Bessell E; Bromberg J; Hottinger AF; Preusser M; Rudà R; Schlegel U; Siegal T; Soussain C; Abacioglu U; Cassoux N; Deckert M; Dirven CM; Ferreri AJ; Graus F; Henriksson R; Herrlinger U; Taphoorn M; Soffietti R; Weller M;
Lancet Oncol; 2015 Jul; 16(7):e322-32. PubMed ID: 26149884
[TBL] [Abstract][Full Text] [Related]
30. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.
Cardoso F; Senkus E; Costa A; Papadopoulos E; Aapro M; André F; Harbeck N; Aguilar Lopez B; Barrios CH; Bergh J; Biganzoli L; Boers-Doets CB; Cardoso MJ; Carey LA; Cortés J; Curigliano G; Diéras V; El Saghir NS; Eniu A; Fallowfield L; Francis PA; Gelmon K; Johnston SRD; Kaufman B; Koppikar S; Krop IE; Mayer M; Nakigudde G; Offersen BV; Ohno S; Pagani O; Paluch-Shimon S; Penault-Llorca F; Prat A; Rugo HS; Sledge GW; Spence D; Thomssen C; Vorobiof DA; Xu B; Norton L; Winer EP
Ann Oncol; 2018 Aug; 29(8):1634-1657. PubMed ID: 30032243
[No Abstract] [Full Text] [Related]
31. [Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): introduction and methodology].
Mesejo A; Vaquerizo Alonso C; Acosta Escribano J; Ortiz Leyba C; Montejo González JC;
Med Intensiva; 2011 Nov; 35 Suppl 1():1-6. PubMed ID: 22309744
[TBL] [Abstract][Full Text] [Related]
32. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010.
Felip E; Gridelli C; Baas P; Rosell R; Stahel R;
Ann Oncol; 2011 Jul; 22(7):1507-1519. PubMed ID: 21536661
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.
Lebbe C; Becker JC; Grob JJ; Malvehy J; Del Marmol V; Pehamberger H; Peris K; Saiag P; Middleton MR; Bastholt L; Testori A; Stratigos A; Garbe C;
Eur J Cancer; 2015 Nov; 51(16):2396-403. PubMed ID: 26257075
[TBL] [Abstract][Full Text] [Related]
34. Gynecologic Oncologist Perspective About ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer.
Dursun P; Ayhan A
Int J Gynecol Cancer; 2017 May; 27(4):826-831. PubMed ID: 28441254
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer: ESMO Consensus Conference Guidelines 2012.
Horwich A; Hugosson J; de Reijke T; Wiegel T; Fizazi K; Kataja V; ;
Ann Oncol; 2013 May; 24(5):1141-62. PubMed ID: 23303340
[TBL] [Abstract][Full Text] [Related]
36. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Tarantino P; Viale G; Press MF; Hu X; Penault-Llorca F; Bardia A; Batistatou A; Burstein HJ; Carey LA; Cortes J; Denkert C; Diéras V; Jacot W; Koutras AK; Lebeau A; Loibl S; Modi S; Mosele MF; Provenzano E; Pruneri G; Reis-Filho JS; Rojo F; Salgado R; Schmid P; Schnitt SJ; Tolaney SM; Trapani D; Vincent-Salomon A; Wolff AC; Pentheroudakis G; André F; Curigliano G
Ann Oncol; 2023 Aug; 34(8):645-659. PubMed ID: 37269905
[TBL] [Abstract][Full Text] [Related]
37. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
Lowrance WT; Breau RH; Chou R; Chapin BF; Crispino T; Dreicer R; Jarrard DF; Kibel AS; Morgan TM; Morgans AK; Oh WK; Resnick MJ; Zietman AL; Cookson MS
J Urol; 2021 Jan; 205(1):14-21. PubMed ID: 32960679
[TBL] [Abstract][Full Text] [Related]
38. Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.
Kwong YL; Anderson BO; Advani R; Kim WS; Levine AM; Lim ST;
Lancet Oncol; 2009 Nov; 10(11):1093-101. PubMed ID: 19880063
[TBL] [Abstract][Full Text] [Related]
39. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.
Ferreri AJ; Abrey LE; Blay JY; Borisch B; Hochman J; Neuwelt EA; Yahalom J; Zucca E; Cavalli F; Armitage J; Batchelor T
J Clin Oncol; 2003 Jun; 21(12):2407-14. PubMed ID: 12805341
[TBL] [Abstract][Full Text] [Related]
40. Discrepancies between NCCN and ESMO guidelines in the management of anal cancer: a qualitative review.
Johnson N; Pellino G; Simillis C; Qiu S; Nikolaou S; Baird DL; Rasheed S; Tekkis PP; Kontovounisios C
Updates Surg; 2017 Sep; 69(3):345-349. PubMed ID: 28597183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
